ONeil Trader is a former stockbroker who has transitioned into a full-time independent investor. His primary focus lies in identifying growth and biotech stocks that exhibit significant growth potential. He employs a strategy that emphasizes the calculation of ideas based on optimal risk-adjusted returns.
Leading the investing group Growth Stock Forum, ONeil Trader offers a wealth of resources for investors. The forum features a model portfolio consisting of 15-20 stocks that are regularly updated, along with a curated list of top picks—up to 10 stocks anticipated to perform well throughout the current calendar year. Additionally, the forum provides trading ideas aimed at both short-term and medium-term market movements, fostering community dialogue and allowing for questions and discussions among members. Learn More.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of GMAB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This article reflects the author’s opinion and should not be regarded as a buy or sell recommendation or investment advice in any way.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
